South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

CIRM is governed by 35 dedicated Californians representing patients, researchers and the biotechnology industry whose knowledge, passion and commitment to CIRM’s mission has guided the organization ...

Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following: Once we have called for public comment, members of the ...

The Bridges to Stem Cell Research (BSCR) program at California State University Fullerton (CSUF) has provided academic and practical training in stem cell research to 118 undergraduate students since ...

Members of the public may attend this meeting in person at the address printed above or remotely via the options listed below. Call to Order Roll Call Discussion of ICOC Chair, ICOC Vice-chair, and ...

Las reuniones de la CFAOC están organizadas por la Oficina del Contralor del Estado. A continuación, se incluye una copia de la agenda publicada en https://www.sco ...

Science and Task Force on Neuroscience and Medicine Joint Meeting September 13, 2024 Transcripts ...

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem ...

What is the California Institute for Regenerative Medicine (CIRM)? CIRM, California’s Stem Cell Agency, was created by the voters of California in 2004 when they overwhelmingly passed Proposition 71, ...

Deborah K. Armstrong Johns Hopkins University Ovarian, Breast Cancer and Gynecologic Cancer Clinical Trials; Genetics of Familial Breast and Ovarian Cancer ...

San Francisco, CA – California’s stem cell agency, the California Institute for Regenerative Medicine (CIRM) today approved $150 million in new funding to help move promising stem cell-based therapies ...

Over 6 million people in the US suffer from AD. There are no drugs that prevent the death of nerve cells in AD, nor has any drug been identified that can stimulate their replacement. Even if nerve ...